Along with increased depressive behaviors, one line of GPR39 KO mice also had reduced thymus weight, reduced splenocyte viability, decreased proliferative immune responses, and decreased interleukin (IL)-1b/IL-6 release after LPS-induced sepsis; this parallels the components of immune dysregulation observed in depression patients [39]. Here, GPR39 is linked to depressive symptom measurement.